{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:23:19Z","timestamp":1794964999972,"version":"4.9.1"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01513-y","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:14:46Z","timestamp":1787235286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive overview of AI methodologies in nano-drug delivery Optimization and Design"],"prefix":"10.1038","volume":"10","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"1513_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2022.100965","volume":"31","author":"Z Dlamini","year":"2022","unstructured":"Dlamini, Z. et al. AI and precision oncology in clinical cancer genomics: from prevention to targeted cancer therapies-an outcomes based patient care. Inform. Med. Unlocked 31, 100965 (2022).","journal-title":"Inform. Med. Unlocked"},{"key":"1513_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1158\/1541-7786.MCR-17-0378","volume":"16","author":"MQ Ding","year":"2018","unstructured":"Ding, M. Q., Cooper, G. F., Chen, L., Lu, X. & Young, J. D. Precision oncology beyond targeted therapy: combining omics data with machine learning matches the majority of cancer cells to effective therapeutics. Mol. Cancer Res. 16, 269\u2013278 (2018).","journal-title":"Mol. Cancer Res."},{"key":"1513_CR3","doi-asserted-by":"publisher","unstructured":"Afrose, N., Hazra, A., Bhowmick, P., Chakraborty, R. & Bhowmick, M. AI-Driven Drug Discovery and Development. 259\u2013277. https:\/\/doi.org\/10.4018\/979-8-3693-3629-8.ch013 (2024).","DOI":"10.4018\/979-8-3693-3629-8.ch013"},{"key":"1513_CR4","doi-asserted-by":"publisher","unstructured":"Pavunraj, D., Anbumaheshwari, K. & Mathan Kumar, A. AI in Personalized Treatment Planning. 117\u2013142. https:\/\/doi.org\/10.4018\/979-8-3373-1275-0.ch006 (2025).","DOI":"10.4018\/979-8-3373-1275-0.ch006"},{"key":"1513_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/pcm.2024.4","volume":"2","author":"A Wenteler","year":"2024","unstructured":"Wenteler, A., Cabrera, C. P., Wei, W., Neduva, V. & Barnes, M. R. AI approaches for the discovery and validation of drug targets. Camb. Prisms Precis. Med. 2, 1\u201344 (2024).","journal-title":"Camb. Prisms Precis. Med."},{"key":"1513_CR6","doi-asserted-by":"publisher","unstructured":"Zhang, W., Chien, J., Yong, J. & Kuang, R. Network-based machine learning and graph theory algorithms for precision oncology. NPJ Precision Oncol. 1. https:\/\/doi.org\/10.1038\/s41698-017-0029-7 (2017).","DOI":"10.1038\/s41698-017-0029-7"},{"key":"1513_CR7","doi-asserted-by":"publisher","unstructured":"Wei, L. et al. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration. Br. J. Radiol. 96. https:\/\/doi.org\/10.1259\/bjr.20230211 (2023).","DOI":"10.1259\/bjr.20230211"},{"key":"1513_CR8","doi-asserted-by":"publisher","first-page":"28485","DOI":"10.1021\/acsomega.4c02308","volume":"9","author":"L Han","year":"2024","unstructured":"Han, L., Guo, Q. & Kang, L. ImageDTA: a simple model for drug-target binding affinity prediction. ACS Omega 9, 28485\u201328493 (2024).","journal-title":"ACS Omega"},{"key":"1513_CR9","doi-asserted-by":"publisher","unstructured":"Zeng, X., Li, S. J., Lv, S. Q., Wen, M. L. & Li, Y. A comprehensive review of the recent advances on predicting drug-target affinity based on deep learning. Front. Pharmacol. 15 https:\/\/doi.org\/10.3389\/fphar.2024.1375522 (2024).","DOI":"10.3389\/fphar.2024.1375522"},{"key":"1513_CR10","doi-asserted-by":"publisher","unstructured":"Ding, H. et al. Application of convolutional neural networks and recurrent neural networks in food safety. https:\/\/doi.org\/10.3390\/foods14020247 (2025).","DOI":"10.3390\/foods14020247"},{"key":"1513_CR11","doi-asserted-by":"publisher","unstructured":"Li, Z. et al. Ensemble pretrained language models to extract biomedical knowledge from literature. J. Am. Med. Inform. Associat. JAMIA 31 https:\/\/doi.org\/10.1093\/jamia\/ocae061 (2024).","DOI":"10.1093\/jamia\/ocae061"},{"key":"1513_CR12","doi-asserted-by":"publisher","unstructured":"Srivastava, R. Advancing precision oncology with AI-powered genomic analysis. Front. Pharmacol. 16 https:\/\/doi.org\/10.3389\/fphar.2025.1591696 (2025).","DOI":"10.3389\/fphar.2025.1591696"},{"key":"1513_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.5498\/wjp.v14.i8.1148","volume":"14","author":"UE Okpete","year":"2024","unstructured":"Okpete, U. E. & Byeon, H. Challenges and prospects in bridging precision medicine and artificial intelligence in genomic psychiatric treatment. World J. Psychiatry 14, 1148\u20131164 (2024).","journal-title":"World J. Psychiatry"},{"key":"1513_CR14","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.3390\/cancers16223884","volume":"16","author":"P Garg","year":"2024","unstructured":"Garg, P. et al. Artificial intelligence\u2013driven computational approaches in the development of anticancer drugs. Cancers 16, 3884 (2024).","journal-title":"Cancers"},{"key":"1513_CR15","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/app15052798","volume":"15","author":"S Herr\u00e1iz-Gil","year":"2025","unstructured":"Herr\u00e1iz-Gil, S., Nygren-Jim\u00e9nez, E., Acosta-Alonso, D. N., Le\u00f3n, C. & Guerrero-Aspizua, S. Artificial intelligence-based methods for drug repurposing and development in cancer. Appl. Sci. 15, 2798 (2025).","journal-title":"Appl. Sci."},{"key":"1513_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100132","volume":"3","author":"A Akingbola","year":"2024","unstructured":"Akingbola, A., Adegbesan, A., Ojo, O., Otumara, J. U. & Alao, U. H. Artificial intelligence and cancer care in Africa. J. Med. Surg. Public Health 3, 100132 (2024).","journal-title":"J. Med. Surg. Public Health"},{"key":"1513_CR17","doi-asserted-by":"publisher","first-page":"1579922","DOI":"10.3389\/fdsfr.2025.1579922","volume":"5","author":"A Horst","year":"2025","unstructured":"Horst, A., Loustalot, P., Yoganathan, S., Li, T., Xu, J., Tong, W., Schneider, D., L\u00f6ffler-Perez, N., Di Renzo, E. & Renaudin, M. Federated learning: a privacy-preserving approach to data-centric regulatory cooperation. Front. Drug Saf. Regul. 5, 1579922 https:\/\/doi.org\/10.3389\/fdsfr.2025.1579922 (2025).","journal-title":"Front. Drug Saf. Regul."},{"key":"1513_CR18","doi-asserted-by":"publisher","unstructured":"Bhange, M. & Telange, D. Convergence of nanotechnology and artificial intelligence in the fight against liver cancer: a comprehensive review. Discov. Oncol. 16, https:\/\/doi.org\/10.1007\/s12672-025-01821-y (2025).","DOI":"10.1007\/s12672-025-01821-y"},{"key":"1513_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.47852\/bonviewMEDIN32021546","volume":"1","author":"AA Bratei","year":"2024","unstructured":"Bratei, A. A. & Stefan-van Staden, R. I. The importance of KRAS quantification for a clinicopathological characterization in colorectal cancer patients. Medinformatics 1, 20\u201326 (2024).","journal-title":"Medinformatics"},{"key":"1513_CR20","doi-asserted-by":"publisher","first-page":"38832","DOI":"10.1021\/acsami.4c07665","volume":"16","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. AI-powered microfluidics: shaping the future of phenotypic drug discovery. ACS Appl. Mater. Interfaces 16, 38832\u201338851 (2024).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1513_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/pharmaceutics17050555","volume":"17","author":"AK Srivastav","year":"2025","unstructured":"Srivastav, A. K., Mishra, M. K., Lillard, J. W. & Singh, R. Transforming pharmacogenomics and CRISPR gene editing with the power of artificial intelligence for precision medicine. Pharmaceutics 17, 555 (2025).","journal-title":"Pharmaceutics"},{"key":"1513_CR22","doi-asserted-by":"publisher","unstructured":"Alharbi, F., Vakanski, A., Mohammed, M. & Elbashir, M. K. LASSO\u2013MOGAT: a multi-omics graph attention framework for cancer classification. Academia Biol. 2, https:\/\/doi.org\/10.20935\/acadbiol7325 (2024).","DOI":"10.20935\/acadbiol7325"},{"key":"1513_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.117003","volume":"72","author":"FJ Fan","year":"2022","unstructured":"Fan, F. J. & Shi, Y. Effects of data quality and quantity on deep learning for protein-ligand binding affinity prediction. Bioorg. Med. Chem. 72, 117003 (2022).","journal-title":"Bioorg. Med. Chem."},{"key":"1513_CR24","doi-asserted-by":"publisher","unstructured":"Ngo, K., Yang, P. C., Clancy, C. E., Vorobyov, I. & Yarov-Yarovoy, V. Harnessing AlphaFold to reveal hERG channel conformational state secrets. eLife 13, https:\/\/doi.org\/10.7554\/elife.104901 (2025).","DOI":"10.7554\/elife.104901"},{"key":"1513_CR25","doi-asserted-by":"publisher","unstructured":"Basnet, B. B., Zhou, Z. Y., Wei, B. & Wang, H. Advances in AI-based strategies and tools to facilitate natural product and drug development. Critical Rev. Biotechnol. https:\/\/doi.org\/10.1080\/07388551.2025.2478094 (2025).","DOI":"10.1080\/07388551.2025.2478094"},{"key":"1513_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/msb.2011.35","volume":"7","author":"O Folger","year":"2011","unstructured":"Folger, O. et al. Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7, 501 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"1513_CR27","doi-asserted-by":"publisher","unstructured":"Wang, Y., Yan, K., Wang, J., Lin, J. & Bi, J. M2 Macrophage co-expression factors correlate with immune phenotype and predict prognosis of bladder cancer. Front Oncol. 11, https:\/\/doi.org\/10.3389\/fonc.2021.609334 (2021).","DOI":"10.3389\/fonc.2021.609334"},{"key":"1513_CR28","doi-asserted-by":"publisher","unstructured":"Lutz, E. A. et al. Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies. Proc. Natl. Acad. Sci. 119, https:\/\/doi.org\/10.1073\/pnas.2205983119 (2022).","DOI":"10.1073\/pnas.2205983119"},{"key":"1513_CR29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/genes11080942","volume":"11","author":"R Spreafico","year":"2020","unstructured":"Spreafico, R., Telenti, A., Soriaga, L. B., Virgin, H. W. & Grosse, J. Advances in genomics for drug development. Genes 11, 942 (2020).","journal-title":"Genes"},{"key":"1513_CR30","doi-asserted-by":"publisher","unstructured":"Razzaq, M. K. et al. Omics and CRISPR-Cas9 approaches for molecular insight, functional gene analysis, and stress tolerance development in crops. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22031292 (2021).","DOI":"10.3390\/ijms22031292"},{"key":"1513_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.60087\/jklst.vol3.n3.p.206-224","volume":"2959-6386","author":"D Huang","year":"2024","unstructured":"Huang, D., Yang, M., Xia, S., Yuan, B. & Wen, X. AI-driven drug discovery: accelerating the development of novel therapeutics in biopharmaceuticals. J. Knowl. Learn. Sci. Technol. ISSN 2959-6386, 206\u2013224 (2024).","journal-title":"J. Knowl. Learn. Sci. Technol. ISSN"},{"key":"1513_CR32","doi-asserted-by":"publisher","unstructured":"Kiriiri, G. K., Mwangi, A. N. & Njogu, P. M. Exploring different approaches to improve the success of drug discovery and development projects: a review. Future J. Pharmaceut. Sci. 6, https:\/\/doi.org\/10.1186\/s43094-020-00047-9 (2020).","DOI":"10.1186\/s43094-020-00047-9"},{"key":"1513_CR33","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.2174\/0109298673252287240215103035","volume":"32","author":"Y Tang","year":"2025","unstructured":"Tang, Y., Li, Y., Li, P. & Liu, Z. P. Drug-target affinity prediction by molecule secondary structure representation network. Curr. Med. Chem. 32, 5095\u20135105 (2025).","journal-title":"Curr. Med. Chem."},{"key":"1513_CR34","doi-asserted-by":"publisher","first-page":"12233","DOI":"10.3390\/ijms252212233","volume":"25","author":"AY Patne","year":"2024","unstructured":"Patne, A. Y. et al. Drug discovery in the age of artificial intelligence: transformative target-based approaches. Int. J. Mol. Sci. 25, 12233 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1513_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104133","volume":"29","author":"A Lavecchia","year":"2024","unstructured":"Lavecchia, A. Navigating the frontier of drug-like chemical space with cutting-edge generative AI models. Drug Discov. Today 29, 104133 (2024).","journal-title":"Drug Discov. Today"},{"key":"1513_CR36","doi-asserted-by":"publisher","unstructured":"Naithani, U. & Guleria, V. Integrative computational approaches for discovery and evaluation of lead compound for drug design. Front. Drug Discov. 4, https:\/\/doi.org\/10.3389\/fddsv.2024.1362456 (2024).","DOI":"10.3389\/fddsv.2024.1362456"},{"key":"1513_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong, G. et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 49, 5\u201314 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1513_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.47852\/bonviewMEDIN42022049","volume":"1","author":"S He","year":"2024","unstructured":"He, S., Ye, X. & Sakurai, T. CLOP-hERG: the contrastive learning optimized pre-trained model for representation learning in predicting drug-induced hERG channel blockers. Medinformatics 1, 103\u2013111 (2024).","journal-title":"Medinformatics"},{"key":"1513_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nrd710","volume":"1","author":"R Ulrich","year":"2002","unstructured":"Ulrich, R. & Friend, S. H. Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nat. Rev. Drug Discov. 1, 84\u201388 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1513_CR40","doi-asserted-by":"crossref","unstructured":"Cui, H. et al. LUMI-lab: a Foundation Model-Driven Autonomous Platform Enabling Discovery of New Ionizable Lipid Designs for mRNA Delivery (Cold Spring Harbor Laboratory, 2025).","DOI":"10.1101\/2025.02.14.638383"},{"key":"1513_CR41","doi-asserted-by":"publisher","unstructured":"Singh, S., Kumar, R., Payra, S. & Singh, S. K. Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery. Cureus 15, https:\/\/doi.org\/10.7759\/cureus.44359 (2023).","DOI":"10.7759\/cureus.44359"},{"key":"1513_CR42","doi-asserted-by":"publisher","unstructured":"Gonda, A. et al. Engineering tumor-targeting nanoparticles as vehicles for precision nanomedicine. Med. One 4, https:\/\/doi.org\/10.20900\/mo.20190021 (2019).","DOI":"10.20900\/mo.20190021"},{"key":"1513_CR43","doi-asserted-by":"publisher","unstructured":"Kapoor, D. U. et al. AI-driven design and optimization of nanoparticle-based drug delivery systems. Sci. Eng. Health Stud. 24010003. https:\/\/doi.org\/10.69598\/sehs.18.24010003 (2024).","DOI":"10.69598\/sehs.18.24010003"},{"key":"1513_CR44","doi-asserted-by":"publisher","unstructured":"Yu, F., Deng, P., Wei, C., Hu, X. & Peng, T. Deep exploration of random forest model boosts the interpretability of machine learning studies of complicated immune responses and lung burden of nanoparticles. Sci. Adv. 7, https:\/\/doi.org\/10.1126\/sciadv.abf4130 (2021).","DOI":"10.1126\/sciadv.abf4130"},{"key":"1513_CR45","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/smll.201201390","volume":"9","author":"X Duan","year":"2012","unstructured":"Duan, X. & Li, Y. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small 9, 1521\u20131532 (2012).","journal-title":"Small"},{"key":"1513_CR46","doi-asserted-by":"publisher","unstructured":"Kumar, A. et al. Recent trends in nanocarrier-based drug delivery system for prostate cancer. AAPS PharmSciTech 25, https:\/\/doi.org\/10.1208\/s12249-024-02765-2 (2024).","DOI":"10.1208\/s12249-024-02765-2"},{"key":"1513_CR47","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1007\/s12274-018-2132-7","volume":"11","author":"Y Li","year":"2018","unstructured":"Li, Y., Zhang, Y. & Wang, W. Phototriggered targeting of nanocarriers for drug delivery. Nano Res. 11, 5424\u20135438 (2018).","journal-title":"Nano Res."},{"key":"1513_CR48","doi-asserted-by":"publisher","unstructured":"Shabbir, F., Mujeeb, A. A., Jawed, S. F., Khan, A. H. & Shakeel, C. S. Simulation of transvascular transport of nanoparticles in tumor microenvironments for drug delivery applications. Sci. Rep. 14, https:\/\/doi.org\/10.1038\/s41598-024-52292-0 (2024).","DOI":"10.1038\/s41598-024-52292-0"},{"key":"1513_CR49","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2217\/17435889.2.5.669","volume":"2","author":"EM Pridgen","year":"2007","unstructured":"Pridgen, E. M., Farokhzad, O. C. & Langer, R. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine 2, 669\u2013680 (2007).","journal-title":"Nanomedicine"},{"key":"1513_CR50","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1021\/acsmacrolett.0c00488","volume":"9","author":"H Sun","year":"2020","unstructured":"Sun, H. & Zhong, Z. 100th Anniversary of macromolecular science viewpoint: biological stimuli-sensitive polymer prodrugs and nanoparticles for tumor-specific drug delivery. ACS Macro Lett. 9, 1292\u20131302 (2020).","journal-title":"ACS Macro Lett."},{"key":"1513_CR51","doi-asserted-by":"publisher","unstructured":"Wu, D. et al. Mesoporous Polydopamine Carrying Manganese Carbonyl Responds to Tumor Microenvironment for Multimodal Imaging-Guided Cancer Therapy. https:\/\/doi.org\/10.1002\/adfm.201900095 (2019).","DOI":"10.1002\/adfm.201900095"},{"key":"1513_CR52","doi-asserted-by":"publisher","first-page":"14021","DOI":"10.1021\/jacs.7b08303","volume":"139","author":"D Wang","year":"2017","unstructured":"Wang, D. et al. A molecular recognition approach to synthesize nucleoside analogue based multifunctional nanoparticles for targeted cancer therapy. J. Am. Chem. Soc. 139, 14021\u201314024 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"1513_CR53","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1021\/acsami.5b09585","volume":"8","author":"N Lu","year":"2016","unstructured":"Lu, N. et al. Smart cancer cell targeting imaging and drug delivery system by systematically engineering periodic mesoporous organosilica nanoparticles. ACS Appl. Mater. Interfaces 8, 2985\u20132993 (2016).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1513_CR54","doi-asserted-by":"publisher","unstructured":"Oh, J. Y. et al. Cloaking nanoparticles with protein corona shield for targeted drug delivery. Nat. Commun. 9, https:\/\/doi.org\/10.1038\/s41467-018-06979-4 (2018).","DOI":"10.1038\/s41467-018-06979-4"},{"key":"1513_CR55","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41565-018-0171-6","volume":"13","author":"M Tonigold","year":"2018","unstructured":"Tonigold, M. et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona. Nat. Nanotechnol. 13, 862\u2013869 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"1513_CR56","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1021\/acs.nanolett.9b01774","volume":"19","author":"J Ren","year":"2019","unstructured":"Ren, J. et al. Precision nanomedicine development based on specific opsonization of human cancer patient-personalized protein coronas. Nano Lett. 19, 4692\u20134701 (2019).","journal-title":"Nano Lett."},{"key":"1513_CR57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/17425247.2023.2167978","volume":"20","author":"J Zaslavsky","year":"2023","unstructured":"Zaslavsky, J., Bannigan, P. & Allen, C. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence. Expert Opin. Drug Deliv. 20, 241\u2013257 (2023).","journal-title":"Expert Opin. Drug Deliv."},{"key":"1513_CR58","doi-asserted-by":"publisher","unstructured":"Jena, G. K., Patra, C. N., Rana, R., Chand, S. & Jammula, S. Artificial intelligence and machine learning implemented drug delivery systems: a paradigm shift in the pharmaceutical industry. J. Bio-X Res. 7, https:\/\/doi.org\/10.34133\/jbioxresearch.0016 (2024).","DOI":"10.34133\/jbioxresearch.0016"},{"key":"1513_CR59","doi-asserted-by":"publisher","unstructured":"Jahandoost, A., Dashti, R., Houshmand, M. & Hosseini, S. A. Utilizing machine learning and molecular dynamics for enhanced drug delivery in nanoparticle systems. Sci. Rep. 14, https:\/\/doi.org\/10.1038\/s41598-024-73268-0 (2024).","DOI":"10.1038\/s41598-024-73268-0"},{"key":"1513_CR60","doi-asserted-by":"publisher","unstructured":"Havelikar, U. et al. Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines. Discover. Nano 19, https:\/\/doi.org\/10.1186\/s11671-024-04118-1 (2024).","DOI":"10.1186\/s11671-024-04118-1"},{"key":"1513_CR61","doi-asserted-by":"publisher","first-page":"214","DOI":"10.18034\/ra.v6i3.672","volume":"6","author":"RR Kundavaram","year":"2018","unstructured":"Kundavaram, R. R. et al. Predictive analytics and generative ai for optimizing cer-vical and breast cancer outcomes: a data-centric approach. ABC Res. Alert 6, 214\u2013223 (2018).","journal-title":"ABC Res. Alert"},{"key":"1513_CR62","doi-asserted-by":"publisher","unstructured":"Singh, A. V. et al. in Artificial Intelligence and Machine Learning Empower Advanced Biomedical Material Design to Toxicity Prediction. https:\/\/doi.org\/10.1002\/aisy.202000084 (2020).","DOI":"10.1002\/aisy.202000084"},{"key":"1513_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.20892\/j.issn.2095-3941.2016.0003","volume":"13","author":"Y Xue","year":"2016","unstructured":"Xue, Y. & Wilcox, W. Changing paradigm of cancer therapy: precision medicine by next-generation sequencing. Cancer Biol. Med. 13, 12\u201318 (2016).","journal-title":"Cancer Biol. Med."},{"key":"1513_CR64","doi-asserted-by":"publisher","unstructured":"Yan, T. & Shi, J. Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy. Front. Immunol. 15, https:\/\/doi.org\/10.3389\/fimmu.2024.1509195 (2024).","DOI":"10.3389\/fimmu.2024.1509195"},{"key":"1513_CR65","doi-asserted-by":"publisher","unstructured":"Iqbal, M. J. et al. Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future. Cancer Cell Int. 21, https:\/\/doi.org\/10.1186\/s12935-021-01981-1 (2021).","DOI":"10.1186\/s12935-021-01981-1"},{"key":"1513_CR66","doi-asserted-by":"publisher","unstructured":"Mao, Y. et al. Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges. Mol. Cancer 24, https:\/\/doi.org\/10.1186\/s12943-025-02321-x (2025).","DOI":"10.1186\/s12943-025-02321-x"},{"key":"1513_CR67","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/curroncol29030146","volume":"29","author":"H Qiu","year":"2022","unstructured":"Qiu, H., Liu, J., Ding, S., Wang, X. & Wang, L. Applications of artificial intelligence in screening, diagnosis, treatment, and prognosis of colorectal cancer. Curr. Oncol. 29, 1773\u20131795 (2022).","journal-title":"Curr. Oncol."},{"key":"1513_CR68","first-page":"175883592093608","volume":"12","author":"G Martini","year":"2020","unstructured":"Martini, G. et al. Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer. Therapeutic Adv. Med. Oncol. 12, 175883592093608 (2020).","journal-title":"Therapeutic Adv. Med. Oncol."},{"key":"1513_CR69","doi-asserted-by":"publisher","unstructured":"Ma, J. & Motsinger-Reif, A. Prediction of synergistic drug combinations using PCA-initialized deep learning. BioData Mining 14, https:\/\/doi.org\/10.1186\/s13040-021-00278-3 (2021).","DOI":"10.1186\/s13040-021-00278-3"},{"key":"1513_CR70","doi-asserted-by":"publisher","unstructured":"Claret, S. P. A., Dharmian, J. P. & Manokar, A. M. Artificial intelligence-driven enhanced skin cancer diagnosis: leveraging convolutional neural networks with discrete wavelet transformation. Egyptian J. Med. Hum. Genet. 25, https:\/\/doi.org\/10.1186\/s43042-024-00522-5 (2024).","DOI":"10.1186\/s43042-024-00522-5"},{"key":"1513_CR71","doi-asserted-by":"publisher","unstructured":"Athaya, T., Ripan, R. C., Li, X. & Hu, H. Multimodal deep learning approaches for single-cell multi-omics data integration. Briefings Bioinformat. 24, https:\/\/doi.org\/10.1093\/bib\/bbad313 (2023).","DOI":"10.1093\/bib\/bbad313"},{"key":"1513_CR72","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. CD8+ T cell co-expressed genes correlate with clinical phenotype and microenvironments of urothelial cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.553399 (2020).","DOI":"10.3389\/fonc.2020.553399"},{"key":"1513_CR73","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1109\/JPROC.2021.3055400","volume":"109","author":"L Ruiz","year":"2021","unstructured":"Ruiz, L., Gama, F. & Ribeiro, A. Graph neural networks: architectures, stability, and transferability. Proc. IEEE 109, 660\u2013682 (2021).","journal-title":"Proc. IEEE"},{"key":"1513_CR74","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41556-021-00654-5","volume":"23","author":"B Ponsioen","year":"2021","unstructured":"Ponsioen, B. et al. Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling. Nat. Cell Biol. 23, 377\u2013390 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1513_CR75","doi-asserted-by":"publisher","first-page":"1000557","DOI":"10.1371\/journal.pcbi.1000557","volume":"5","author":"J Foo","year":"2009","unstructured":"Foo, J. & Michor, F. Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies. PLoS Comput. Biol. 5, 1000557 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"1513_CR76","doi-asserted-by":"publisher","unstructured":"Ma, Y. & Newton, P. K. Role of synergy and antagonism in designing multidrug adaptive chemotherapy schedules. Phys. Rev. E 103, https:\/\/doi.org\/10.1103\/physreve.103.032408 (2021).","DOI":"10.1103\/physreve.103.032408"},{"key":"1513_CR77","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1158\/1078-0432.CCR-22-0390","volume":"29","author":"N Ghaffari Laleh","year":"2022","unstructured":"Ghaffari Laleh, N., Kather, J. N., Ligero, M. & Perez-Lopez, R. Facts and hopes on the use of artificial intelligence for predictive immunotherapy biomarkers in cancer. Clin. Cancer Res. 29, 316\u2013323 (2022).","journal-title":"Clin. Cancer Res."},{"key":"1513_CR78","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1158\/0008-5472.CAN-17-0122","volume":"77","author":"E Rios Velazquez","year":"2017","unstructured":"Rios Velazquez, E. et al. Somatic mutations drive distinct imaging phenotypes in lung cancer. Cancer Res. 77, 3922\u20133930 (2017).","journal-title":"Cancer Res."},{"key":"1513_CR79","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/ng.3838","volume":"49","author":"A Morrissy","year":"2017","unstructured":"Morrissy, A. et al. Spatial heterogeneity in medulloblastoma. Nat. Genet. 49, 780\u2013788 (2017).","journal-title":"Nat. Genet."},{"key":"1513_CR80","doi-asserted-by":"publisher","unstructured":"Shi, Z. D. et al. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal Transduction Targeted Ther. 8, https:\/\/doi.org\/10.1038\/s41392-023-01383-x (2023).","DOI":"10.1038\/s41392-023-01383-x"},{"key":"1513_CR81","doi-asserted-by":"publisher","unstructured":"Yan, K., Wang, Y., Lu, Y. & Yan, Z. Coexpressed genes that promote the infiltration of M2 macrophages in melanoma can evaluate the prognosis and immunotherapy outcome. J. Immunol. Res. 2021, https:\/\/doi.org\/10.1155\/2021\/6664791 (2021).","DOI":"10.1155\/2021\/6664791"},{"key":"1513_CR82","doi-asserted-by":"publisher","unstructured":"Xiang, Y. et al. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges. Front. Immunol. 15, https:\/\/doi.org\/10.3389\/fimmu.2024.1366260 (2024).","DOI":"10.3389\/fimmu.2024.1366260"},{"key":"1513_CR83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.47852\/bonviewMEDIN52023816","volume":"2","author":"KR Arya","year":"2025","unstructured":"Arya, K. R. et al. Multitarget-directed multiple ligands in anti-VEGF resistant glioblastoma therapeutics: an in silico approach to identify potential phytochemicals. Medinformatics 2, 57\u201369 (2025).","journal-title":"Medinformatics"},{"key":"1513_CR84","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1159\/000374030","volume":"35","author":"P Nie","year":"2015","unstructured":"Nie, P. et al. Synergistic induction of erlotinib-mediated apoptosis by resveratrol in human non-small-cell lung cancer cells by down-regulating survivin and up-regulating PUMA. Cell. Physiol. Biochem. 35, 2255\u20132271 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"1513_CR85","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17460441.2021.1883585","volume":"16","author":"Z Tanoli","year":"2021","unstructured":"Tanoli, Z., V\u00e4h\u00e4-Koskela, M. & Aittokallio, T. Artificial intelligence, machine learning, and drug repurposing in cancer. Expert Opin. Drug Discov. 16, 977\u2013989 (2021).","journal-title":"Expert Opin. Drug Discov."},{"key":"1513_CR86","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/ph14050470","volume":"14","author":"N Tilija Pun","year":"2021","unstructured":"Tilija Pun, N. & Jeong, C. H. Statin as a potential chemotherapeutic agent: current updates as a monotherapy, combination therapy, and treatment for anti-cancer drug resistance. Pharmaceuticals 14, 470 (2021).","journal-title":"Pharmaceuticals"},{"key":"1513_CR87","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1158\/2159-8290.CD-17-0461","volume":"8","author":"M Rusan","year":"2018","unstructured":"Rusan, M. et al. Suppression of adaptive responses to targeted cancer therapy by transcriptional repression. Cancer Discov. 8, 59\u201373 (2018).","journal-title":"Cancer Discov."},{"key":"1513_CR88","doi-asserted-by":"publisher","unstructured":"Litzenburger, U. M. et al. Single-cell epigenomic variability reveals functional cancer heterogeneity. Genome Biol. 18, https:\/\/doi.org\/10.1186\/s13059-016-1133-7 (2017).","DOI":"10.1186\/s13059-016-1133-7"},{"key":"1513_CR89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/leu.2013.248","volume":"28","author":"DA Landau","year":"2013","unstructured":"Landau, D. A., Carter, S. L., Wu, C. J. & Getz, G. Clonal evolution in hematological malignancies and therapeutic implications. Leukemia 28, 34\u201343 (2013).","journal-title":"Leukemia"},{"key":"1513_CR90","doi-asserted-by":"publisher","unstructured":"Enriquez-Navas, P. M. et al. Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer. Sci. Transl. Med. 8, https:\/\/doi.org\/10.1126\/scitranslmed.aad7842 (2016).","DOI":"10.1126\/scitranslmed.aad7842"},{"key":"1513_CR91","first-page":"10","volume":"2","author":"S Akter","year":"2024","unstructured":"Akter, S. AI-driven precision medicine: transforming personalized cancer treatment. J. AI-Powered Med. Innov. (Int. Online ISSN 3078-1930. 2, 10\u201321 (2024).","journal-title":"J. AI-Powered Med. Innov. (Int. Online ISSN 3078-1930."},{"key":"1513_CR92","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.3390\/app14209404","volume":"14","author":"M \u0141ukaniszyn","year":"2024","unstructured":"\u0141ukaniszyn, M., Grochowicz, B., Kawala-Sterniuk, A., Miko\u0142ajewski, D. & Majka Digital twins generated by artificial intelligence in personalized healthcare. Appl. Sci. 14, 9404 (2024).","journal-title":"Appl. Sci."},{"key":"1513_CR93","doi-asserted-by":"publisher","unstructured":"Sigawi, T. et al. Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial. Front. Oncol. 14, https:\/\/doi.org\/10.3389\/fonc.2024.1426426 (2024).","DOI":"10.3389\/fonc.2024.1426426"},{"key":"1513_CR94","first-page":"31","volume":"1","author":"JG Carrasco Ram\u00edrez","year":"2024","unstructured":"Carrasco Ram\u00edrez, J. G. AI in healthcare: revolutionizing patient care with predictive analytics and decision support systems. J. Artif. Intell. Gen. Sci. (JAIGS) ISSN:3006-4023 1, 31\u201337 (2024).","journal-title":"J. Artif. Intell. Gen. Sci. (JAIGS) ISSN:3006-4023"},{"key":"1513_CR95","doi-asserted-by":"publisher","unstructured":"Fountzilas, E., Pearce, T., Baysal, M. A., Chakraborty, A. & Tsimberidou, A. M. Convergence of evolving artificial intelligence and machine learning techniques in precision oncology. Npj Digit. Med. 8, https:\/\/doi.org\/10.1038\/s41746-025-01471-y (2025).","DOI":"10.1038\/s41746-025-01471-y"},{"key":"1513_CR96","doi-asserted-by":"crossref","unstructured":"Yan, L., Li, Q., Fu, K., Zhou, X. & Zhang, K. in Progress in the Application of Artificial Intelligence in Ultrasound-Assisted Medical Diagnosis. Bioengineering (2025).","DOI":"10.3390\/bioengineering12030288"},{"key":"1513_CR97","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.1039\/C8SC01668B","volume":"9","author":"B Han","year":"2018","unstructured":"Han, B. et al. Multi-omics and temporal dynamics profiling reveal disruption of central metabolism in Helicobacter pylori on bismuth treatment. Chem. Sci. 9, 7488\u20137497 (2018).","journal-title":"Chem. Sci."},{"key":"1513_CR98","doi-asserted-by":"publisher","unstructured":"Wang, Y., Yan, K., Lin, J., Li, J. & Bi, J. Macrophage M2 co-expression factors correlate with the immune microenvironment and predict outcome of renal clear cell carcinoma. Front Genet 12, https:\/\/doi.org\/10.3389\/fgene.2021.615655 (2021).","DOI":"10.3389\/fgene.2021.615655"},{"key":"1513_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100817","volume":"4","author":"S Verma","year":"2024","unstructured":"Verma, S. et al. Cross-attention enables deep learning on limited omics-imaging-clinical data of 130 lung cancer patients. Cell Rep. Methods 4, 100817 (2024).","journal-title":"Cell Rep. Methods"},{"key":"1513_CR100","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1158\/2767-9764.CRC-24-0285","volume":"4","author":"Z Cai","year":"2024","unstructured":"Cai, Z. et al. DeePathNet: a transformer-based deep learning model integrating multiomic data with cancer pathways. Cancer Res. Commun. 4, 3151\u20133164 (2024).","journal-title":"Cancer Res. Commun."},{"key":"1513_CR101","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10796-024-10513-x","volume":"27","author":"S Niu","year":"2024","unstructured":"Niu, S. et al. Modelling patient longitudinal data for clinical decision support: a case study on emerging AI healthcare technologies. Inf. Syst. Front. 27, 409\u2013427 (2024).","journal-title":"Inf. Syst. Front."},{"key":"1513_CR102","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","volume":"16","author":"K Bera","year":"2019","unstructured":"Bera, K., Velcheti, V., Rimm, D. L., Madabhushi, A. & Schalper, K. A. Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology. Nat. Rev. Clin. Oncol. 16, 703\u2013715 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1513_CR103","doi-asserted-by":"publisher","unstructured":"Durga, K. P. Intelligent Support for Cardiovascular Diagnosis. 64\u201376. https:\/\/doi.org\/10.4018\/979-8-3693-0639-0.ch002 (2024).","DOI":"10.4018\/979-8-3693-0639-0.ch002"},{"key":"1513_CR104","doi-asserted-by":"publisher","first-page":"018","DOI":"10.53430\/ijbpru.2024.4.1.0027","volume":"4","author":"G Igwama","year":"2024","unstructured":"Igwama, G., Nwankwo, E., Emeihe, E. & Ajegbile, M. The role of AI in optimizing drug dosage and reducing medication errors. Int. J. Biol. Pharm. Res. Updates 4, 018\u2013034 (2024).","journal-title":"Int. J. Biol. Pharm. Res. Updates"},{"key":"1513_CR105","doi-asserted-by":"publisher","unstructured":"Shen, S. et al. From virtual to reality: innovative practices of digital twins in tumor therapy. J. Transl. Med. 23, https:\/\/doi.org\/10.1186\/s12967-025-06371-z (2025).","DOI":"10.1186\/s12967-025-06371-z"},{"key":"1513_CR106","doi-asserted-by":"publisher","unstructured":"Gazola, A. A., Lautert-Dutra, W., Archangelo, L. F., Reis, R. B. D. & Squire, J. A. Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment. Mol. Cytogenet 17, https:\/\/doi.org\/10.1186\/s13039-024-00698-w (2024).","DOI":"10.1186\/s13039-024-00698-w"},{"key":"1513_CR107","doi-asserted-by":"publisher","first-page":"12527","DOI":"10.3390\/cimb46110744","volume":"46","author":"V Vashisht","year":"2024","unstructured":"Vashisht, V., Vashisht, A., Mondal, A. K., Woodall, J. & Kolhe, R. From genomic exploration to personalized treatment: next-generation sequencing in oncology. Curr. Issues Mol. Biol. 46, 12527\u201312549 (2024).","journal-title":"Curr. Issues Mol. Biol."},{"key":"1513_CR108","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/jamia\/ocz119","volume":"26","author":"T Hernandez-Boussard","year":"2019","unstructured":"Hernandez-Boussard, T., Monda, K. L., Crespo, B. C. & Riskin, D. Real world evidence in cardiovascular medicine: ensuring data validity in electronic health record-based studies. J. Am. Med. Inform. Assoc. JAMIA 26, 1189\u20131194 (2019).","journal-title":"J. Am. Med. Inform. Assoc. JAMIA"},{"key":"1513_CR109","doi-asserted-by":"publisher","unstructured":"Lee, W. C. Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals. Expert Rev. Pharmacoeconom. Outcomes Res. https:\/\/doi.org\/10.1080\/14737167.2023.2275674 (2023).","DOI":"10.1080\/14737167.2023.2275674"},{"key":"1513_CR110","doi-asserted-by":"publisher","first-page":"100966","DOI":"10.1136\/bmjhci-2023-100966","volume":"31","author":"JI Park","year":"2024","unstructured":"Park, J. I., Park, J. W., Zhang, K. & Kim, D. Advancing equity in breast cancer care: natural language processing for analysing treatment outcomes in under-represented populations. BMJ Health Care Inform. 31, 100966 (2024).","journal-title":"BMJ Health Care Inform."},{"key":"1513_CR111","doi-asserted-by":"publisher","first-page":"949","DOI":"10.52783\/jes.1409","volume":"20","author":"S Sharma","year":"2024","unstructured":"Sharma, S. Exploring AI-driven innovations in image communication systems for enhanced medical imaging applications. J. Electr. Syst. 20, 949\u2013959 (2024).","journal-title":"J. Electr. Syst."},{"key":"1513_CR112","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/joim.13030","volume":"288","author":"B Acs","year":"2020","unstructured":"Acs, B., Hartman, J. & Rantalainen, M. Artificial intelligence as the next step towards precision pathology. J. Intern. Med. 288, 62\u201381 (2020).","journal-title":"J. Intern. Med."},{"key":"1513_CR113","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.3390\/cancers14194823","volume":"14","author":"J Shao","year":"2022","unstructured":"Shao, J. et al. Radiogenomic system for non-invasive identification of multiple actionable mutations and PD-L1 expression in non-small cell lung cancer based on CT images. Cancers 14, 4823 (2022).","journal-title":"Cancers"},{"key":"1513_CR114","doi-asserted-by":"publisher","unstructured":"Silva, T. F. D. et al. From haystack to high precision: advanced sequencing methods to unraveling circulating tumor DNA mutations. Front. Mol. Biosci. 11, https:\/\/doi.org\/10.3389\/fmolb.2024.1423470 (2024).","DOI":"10.3389\/fmolb.2024.1423470"},{"key":"1513_CR115","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005344","volume":"11","author":"PJ Vellanki","year":"2023","unstructured":"Vellanki, P. J. et al. Regulatory implications of ctDNA in immuno-oncology for solid tumors. J. Immunother. Cancer 11, 005344 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"1513_CR116","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.11591\/ijai.v13.i3.pp2694-2702","volume":"13","author":"RR Lokare","year":"2024","unstructured":"Lokare, R. R., Patil, S., Wadmare, J., Wadmare, G. & Patil, D. Transparent precision: Explainable AI empowered breast cancer recommendations for personalized treatment. IAES Int. J. Artif. Intell. (IJ-AI) 13, 2694 (2024).","journal-title":"IAES Int. J. Artif. Intell. (IJ-AI)"},{"key":"1513_CR117","doi-asserted-by":"publisher","unstructured":"Mooi Kwong, A. T., Omar, S. I. & Nur Aliah, M. The Ethical Implications of AI-Powered Personalization in Hospitality and Tourism. 103\u2013122. https:\/\/doi.org\/10.4018\/979-8-3693-6755-1.ch006 (2024).","DOI":"10.4018\/979-8-3693-6755-1.ch006"},{"key":"1513_CR118","doi-asserted-by":"publisher","unstructured":"Chen, Z. Ethics and discrimination in artificial intelligence-enabled recruitment practices. Hum. Soc. Sci. Commun. 10, https:\/\/doi.org\/10.1057\/s41599-023-02079-x (2023).","DOI":"10.1057\/s41599-023-02079-x"},{"key":"1513_CR119","doi-asserted-by":"publisher","unstructured":"Mishra, I., Pahwa, D., Yadav, N. & Kashyap, V. Harmonizing intelligence: a holistic approach to bias mitigation in artificial intelligence (AI). Int. Res. J. Adv. Eng. Hub (IRJAEH 2, https:\/\/doi.org\/10.47392\/irjaeh.2024.0270 (2024).","DOI":"10.47392\/irjaeh.2024.0270"},{"key":"1513_CR120","doi-asserted-by":"publisher","first-page":"165","DOI":"10.9734\/ajrcos\/2024\/v17i12536","volume":"17","author":"OO Oguntibeju","year":"2024","unstructured":"Oguntibeju, O. O. Mitigating artificial intelligence bias in financial systems: a comparative analysis of debiasing techniques. Asian J. Res. Comput Sci. 17, 165\u2013178 (2024).","journal-title":"Asian J. Res. Comput Sci."},{"key":"1513_CR121","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/bioengineering11040369","volume":"11","author":"C Metta","year":"2024","unstructured":"Metta, C., Rinzivillo, S., Beretta, A., Giannotti, F. & Pellungrini, R. Towards transparent healthcare: advancing local explanation methods in explainable artificial intelligence. Bioengineering 11, 369 (2024).","journal-title":"Bioengineering"},{"key":"1513_CR122","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5582\/bst.2024.01342","volume":"18","author":"K Karako","year":"2024","unstructured":"Karako, K. & Tang, W. Applications of and issues with machine learning in medicine: Bridging the gap with explainable AI. Biosci. Trends 18, 497\u2013504 (2024).","journal-title":"Biosci. Trends"},{"key":"1513_CR123","doi-asserted-by":"publisher","unstructured":"Pallumeera, M., Giang, J. C., Singh, R., Pracha, N. S. & Makary, M. S. Evolving and novel applications of artificial intelligence in cancer imaging. Cancers 17, https:\/\/doi.org\/10.3390\/cancers17091510 (2025).","DOI":"10.3390\/cancers17091510"},{"key":"1513_CR124","doi-asserted-by":"publisher","unstructured":"Gerke, S., Babic, B., Evgeniou, T. & Cohen, I. G. The need for a system view to regulate artificial intelligence\/machine learning-based software as medical device. NPJ Digit. Med. 3, https:\/\/doi.org\/10.1038\/s41746-020-0262-2 (2020)","DOI":"10.1038\/s41746-020-0262-2"},{"key":"1513_CR125","doi-asserted-by":"publisher","unstructured":"Bouderhem, R. Shaping the future of AI in healthcare through ethics and governance. Hum. Soc. Sci. Commun. 11, https:\/\/doi.org\/10.1057\/s41599-024-02894-w (2024).","DOI":"10.1057\/s41599-024-02894-w"},{"key":"1513_CR126","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Generalizability Assessment of AI Models Across Hospitals: A Comparative Study in Low-Middle Income and High Income Countries (Cold Spring Harbor Laboratory, 2023).","DOI":"10.1101\/2023.11.05.23298109"},{"key":"1513_CR127","doi-asserted-by":"publisher","unstructured":"Voisin, C. et al. GA4GH Passport standard for digital identity and access permissions. Cell Genomics 1, https:\/\/doi.org\/10.1016\/j.xgen.2021.100030 (2021).","DOI":"10.1016\/j.xgen.2021.100030"},{"key":"1513_CR128","doi-asserted-by":"publisher","unstructured":"Kakish, D. R. K. et al. Transforming dermatopathology with AI: addressing bias, enhancing interpretability, and shaping future diagnostics. Dermatol. Rev. 6, https:\/\/doi.org\/10.1002\/der2.70018 (2025).","DOI":"10.1002\/der2.70018"},{"key":"1513_CR129","doi-asserted-by":"publisher","unstructured":"Petru\u0161i\u0107, I. et al. Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members\u2019 vision \u2013 part 2. J. Headache Pain 26, https:\/\/doi.org\/10.1186\/s10194-024-01944-7 (2025).","DOI":"10.1186\/s10194-024-01944-7"},{"key":"1513_CR130","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/17460441.2023.2171396","volume":"18","author":"AU Rehman","year":"2023","unstructured":"Rehman, A. U. et al. Computational approaches for the design of modulators targeting protein-protein interactions. Expert Opin. Drug Discov. 18, 315\u2013333 (2023).","journal-title":"Expert Opin. Drug Discov."},{"key":"1513_CR131","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1109\/JBHI.2023.3284794","volume":"27","author":"S Xiao","year":"2023","unstructured":"Xiao, S., Lin, H., Wang, S., Wang, C. & Rajapakse, J. C. Graph neural networks with multiple prior knowledge for multi-omics data analysis. IEEE J. Biomed. Health Inform. 27, 4591\u20134600 (2023).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"1513_CR132","doi-asserted-by":"publisher","unstructured":"Jiao, P. et al. Struct2GO: protein function prediction based on Graph pooling algorithm and AlphaFold2 structure information. Bioinformatics 39, https:\/\/doi.org\/10.1093\/bioinformatics\/btad637 (2023).","DOI":"10.1093\/bioinformatics\/btad637"},{"key":"1513_CR133","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1074\/mcp.RA117.000335","volume":"17","author":"J Basken","year":"2018","unstructured":"Basken, J. et al. Specificity of phosphorylation responses to mitogen activated protein (MAP) kinase pathway inhibitors in melanoma cells. Mol. Cell. Proteom. 17, 550\u2013564 (2018).","journal-title":"Mol. Cell. Proteom."},{"key":"1513_CR134","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1021\/acs.jcim.3c01211","volume":"64","author":"M Brocidiacono","year":"2023","unstructured":"Brocidiacono, M. et al. BigBind: learning from nonstructural data for structure-based virtual screening. J. Chem. Inf. Model. 64, 2488\u20132495 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"1513_CR135","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1021\/acs.jcim.4c00621","volume":"64","author":"C Shen","year":"2024","unstructured":"Shen, C. et al. DrugFlow: an AI-driven one-stop platform for innovative drug discovery. J. Chem. Inf. Model. 64, 5381\u20135391 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"1513_CR136","doi-asserted-by":"publisher","unstructured":"Bahadar, N. et al. Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer. Breast Cancer Res. 26, https:\/\/doi.org\/10.1186\/s13058-024-01868-9 (2024).","DOI":"10.1186\/s13058-024-01868-9"},{"key":"1513_CR137","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.3390\/ijms24098326","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. MSGNN-DTA: multi-scale topological feature fusion based on graph neural networks for drug-target binding affinity prediction. Int. J. Mol. Sci. 24, 8326 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1513_CR138","doi-asserted-by":"publisher","first-page":"170098","DOI":"10.1183\/16000617.0098-2017","volume":"27","author":"A Boyer","year":"2018","unstructured":"Boyer, A. et al. Drug repurposing in malignant pleural mesothelioma: a breath of fresh air? Eur. Respir. Rev. Off. J. Eur. Respir. Soc. 27, 170098 (2018).","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"1513_CR139","doi-asserted-by":"publisher","first-page":"178","DOI":"10.21037\/atm-23-195","volume":"11","author":"C Tian","year":"2023","unstructured":"Tian, C. et al. Efficacy and safety of IL inhibitors, TNF-\u03b1 inhibitors, and JAK inhibitors in patients with ankylosing spondylitis: a systematic review and Bayesian network meta-analysis. Ann. Transl. Med. 11, 178 (2023).","journal-title":"Ann. Transl. Med."},{"key":"1513_CR140","doi-asserted-by":"publisher","unstructured":"Singh, H., Nim, D. K., Randhawa, A. S. & Ahluwalia, S. Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists. Expert Rev. Clin. Pharmacol. https:\/\/doi.org\/10.1080\/17512433.2024.2317963 (2024).","DOI":"10.1080\/17512433.2024.2317963"},{"key":"1513_CR141","doi-asserted-by":"publisher","first-page":"108","DOI":"10.9734\/jocamr\/2024\/v25i7552","volume":"25","author":"T Khinvasara","year":"2024","unstructured":"Khinvasara, T., Shankar, A. & Tzenios, N. Post-market surveillance of medical devices using AI. J. Complementary Alternative Med. Res. 25, 108\u2013122 (2024).","journal-title":"J. Complementary Alternative Med. Res."},{"key":"1513_CR142","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/1061186X.2025.2467139","volume":"33","author":"F Attarian","year":"2025","unstructured":"Attarian, F. et al. Role of liposomes in chemoimmunotherapy of breast cancer. J. Drug Target. 33, 887\u2013915 (2025).","journal-title":"J. Drug Target."},{"key":"1513_CR143","doi-asserted-by":"publisher","unstructured":"Blume, J. E. et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nat. Commun. 11, https:\/\/doi.org\/10.1038\/s41467-020-17033-7 (2020).","DOI":"10.1038\/s41467-020-17033-7"},{"key":"1513_CR144","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.2174\/0929867325666181009120610","volume":"27","author":"JA Oshiro-J\u00fanior","year":"2020","unstructured":"Oshiro-J\u00fanior, J. A. et al. Stimuli-responsive drug delivery nanocarriers in the treatment of breast cancer. Curr. Med. Chem. 27, 2494\u20132513 (2020).","journal-title":"Curr. Med. Chem."},{"key":"1513_CR145","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.2147\/IJN.S257645","volume":"15","author":"X Tian","year":"2020","unstructured":"Tian, X. et al. Carbon quantum dots: in vitro and in vivo studies on biocompatibility and biointeractions for optical imaging. Int. J. Nanomed. 15, 6519\u20136529 (2020).","journal-title":"Int. J. Nanomed."},{"key":"1513_CR146","doi-asserted-by":"publisher","first-page":"401","DOI":"10.7150\/ntno.95791","volume":"8","author":"J Bonlawar","year":"2024","unstructured":"Bonlawar, J. et al. Targeted nanotheransotics: integration of preclinical MRI and CT in the molecular imaging and therapy of advanced diseases. Nanotheranostics 8, 401\u2013426 (2024).","journal-title":"Nanotheranostics"},{"key":"1513_CR147","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/nano12030399","volume":"12","author":"M Murar","year":"2022","unstructured":"Murar, M., Pujals, S. & Albertazzi, L. Advanced optical imaging-guided nanotheranostics towards personalized cancer drug delivery. Nanomaterials 12, 399 (2022).","journal-title":"Nanomaterials"},{"key":"1513_CR148","doi-asserted-by":"publisher","first-page":"40017","DOI":"10.1021\/acsami.7b11926","volume":"9","author":"Q You","year":"2017","unstructured":"You, Q. et al. BSA-bioinspired gadolinium hybrid-functionalized hollow gold nanoshells for NIRF\/PA\/CT\/MR quadmodal diagnostic imaging-guided photothermal\/photodynamic cancer therapy. ACS Appl. Mater. Interfaces 9, 40017\u201340030 (2017).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1513_CR149","doi-asserted-by":"publisher","unstructured":"Imani, S. et al. Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy. Front. Cell. Infect. Microbiol. 14, https:\/\/doi.org\/10.3389\/fcimb.2024.1501010 (2025).","DOI":"10.3389\/fcimb.2024.1501010"},{"key":"1513_CR150","doi-asserted-by":"publisher","unstructured":"Hu, Q. et al. Circulating tumor DNA: current implementation issues and future challenges for clinical utility. Clin. Chem. Laboratory Med. 62, https:\/\/doi.org\/10.1515\/cclm-2023-1157 (2023).","DOI":"10.1515\/cclm-2023-1157"},{"key":"1513_CR151","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy. J. Nanobiotechnol. 21, https:\/\/doi.org\/10.1186\/s12951-023-01966-4 (2023).","DOI":"10.1186\/s12951-023-01966-4"},{"key":"1513_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. iMLGAM: Integrated Machine Learning and Genetic Algorithm-driven Multiomics analysis for pan-cancer immunotherapy response prediction. Imeta 4, e70011 (2025).","journal-title":"Imeta"},{"key":"1513_CR153","doi-asserted-by":"publisher","unstructured":"Nandipati, M., Fatoki, O. & Desai, S. Bridging nanomanufacturing and artificial intelligence\u2014a comprehensive review. Materials 17, https:\/\/doi.org\/10.3390\/ma17071621 (2024).","DOI":"10.3390\/ma17071621"},{"key":"1513_CR154","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.30574\/ijsra.2024.13.1.1870","volume":"13","author":"A Anang","year":"2024","unstructured":"Anang, A. et al. Explainable AI in financial technologies: Balancing innovation with regulatory compliance. Int. J. Sci. Res. Arch. 13, 1793\u20131806 (2024).","journal-title":"Int. J. Sci. Res. Arch."},{"key":"1513_CR155","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1586\/era.11.34","volume":"11","author":"G Metro","year":"2011","unstructured":"Metro, G. & Crin\u00f2, L. The LUX-Lung clinical trial program of afatinib for non-small-cell lung cancer. Expert Rev. Anticancer Ther. 11, 673\u2013682 (2011).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"1513_CR156","doi-asserted-by":"publisher","unstructured":"Zecena, H. et al. Systems biology analysis of mitogen activated protein kinase inhibitor resistance in malignant melanoma. BMC Syst. Biol. 12, https:\/\/doi.org\/10.1186\/s12918-018-0554-1 (2018).","DOI":"10.1186\/s12918-018-0554-1"},{"key":"1513_CR157","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/emm.2013.115","volume":"45","author":"YY Lee","year":"2013","unstructured":"Lee, Y. Y. et al. Phosphoproteomic analysis identifies activated MET-axis PI3K\/AKT and MAPK\/ERK in lapatinib-resistant cancer cell line. Exp. Mol. Med. 45, 64 (2013).","journal-title":"Exp. Mol. Med."},{"key":"1513_CR158","doi-asserted-by":"publisher","unstructured":"Sahni, S. et al. A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade. Nat. Commun. 15, https:\/\/doi.org\/10.1038\/s41467-024-52555-4 (2024).","DOI":"10.1038\/s41467-024-52555-4"},{"key":"1513_CR159","doi-asserted-by":"publisher","unstructured":"Mason, M. et al. A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. J. Transl. Med. 22, https:\/\/doi.org\/10.1186\/s12967-023-04705-3 (2024).","DOI":"10.1186\/s12967-023-04705-3"},{"key":"1513_CR160","doi-asserted-by":"publisher","unstructured":"Mahmoud, M. M., Sanad, E. F., Elshimy, R. A. A. & Hamdy, N. M. Competitive endogenous role of the LINC00511\/miR-185-3p axis and miR-301a-3p from liquid biopsy as molecular markers for breast cancer diagnosis. Front. Oncol. 11, https:\/\/doi.org\/10.3389\/fonc.2021.749753 (2021).","DOI":"10.3389\/fonc.2021.749753"},{"key":"1513_CR161","doi-asserted-by":"publisher","unstructured":"Chaunzwa, T. L. et al. Deep learning classification of lung cancer histology using CT images. Sci. Rep. 11, https:\/\/doi.org\/10.1038\/s41598-021-84630-x (2021).","DOI":"10.1038\/s41598-021-84630-x"},{"key":"1513_CR162","doi-asserted-by":"publisher","unstructured":"Cui, Y. et al. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment. J. Cell. Mol. Med. 28, https:\/\/doi.org\/10.1111\/jcmm.18374 (2024).","DOI":"10.1111\/jcmm.18374"},{"key":"1513_CR163","doi-asserted-by":"publisher","unstructured":"Lee, H. W. et al. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med. 12, https:\/\/doi.org\/10.1186\/s13073-020-00741-6 (2020).","DOI":"10.1186\/s13073-020-00741-6"},{"key":"1513_CR164","doi-asserted-by":"publisher","unstructured":"Poulet, S. et al. Genome-wide in vivo CRISPR screen identifies TGF\u03b23 as actionable biomarker of palbociclib resistance in triple negative breast cancer. Mol. Cancer 23, https:\/\/doi.org\/10.1186\/s12943-024-02029-4 (2024).","DOI":"10.1186\/s12943-024-02029-4"},{"key":"1513_CR165","doi-asserted-by":"publisher","unstructured":"Fernandes, M. G. O. et al. Liquid biopsy for disease monitoring in non-small cell lung cancer: the link between biology and the clinic. Cells 10, https:\/\/doi.org\/10.3390\/cells10081912 (2021).","DOI":"10.3390\/cells10081912"},{"key":"1513_CR166","doi-asserted-by":"publisher","unstructured":"Chin, Y. M. et al. Serial circulating tumor DNA monitoring of CDK4\/6 inhibitors response in metastatic breast cancer. Cancer Sci. 113, https:\/\/doi.org\/10.1111\/cas.15304 (2022).","DOI":"10.1111\/cas.15304"},{"key":"1513_CR167","doi-asserted-by":"publisher","first-page":"202510239","DOI":"10.1002\/adma.202510239","volume":"37","author":"H Bae","year":"2025","unstructured":"Bae, H. et al. Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery. Adv. Mater. 37, 202510239 (2025).","journal-title":"Adv. Mater."},{"key":"1513_CR168","doi-asserted-by":"publisher","first-page":"70243","DOI":"10.1002\/mco2.70243","volume":"6","author":"T Wolde","year":"2025","unstructured":"Wolde, T., Bhardwaj, V. & Pandey, V. Current bioinformatics tools in precision oncology. MedComm. 6, 70243 (2025).","journal-title":"MedComm."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01513-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:04:06Z","timestamp":1787745846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01513-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":168,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01513-y","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"331"}}